Lumbrokinase vs nattokinase: two enzymes, two units
Lumbrokinase and nattokinase are both described as fibrinolytic enzyme preparations, but they come from different sources and are measured on different assays. Lumbrokinase is an earthworm-derived mixture read on a fibrin plate in U/g; nattokinase is a fermentation protein from Bacillus subtilis natto read in FU/g. The two units are method-specific and do not convert into each other.
Lumbrokinase is sold in fibrin-plate units and nattokinase in FU, and neither unit converts into the other without the method that defined it.
Two enzymes, two unit systems
A unit is a defined amount of activity under a named method, not a mass of enzyme. Lumbrokinase activity is quoted in U/g, read from a lysis zone on a fibrin plate against a standard. Nattokinase activity is quoted in FU/g, a fibrin unit defined by a spectrophotometric reading of fibrin degradation under fixed conditions. The abbreviations are easy to confuse and the substrates overlap, but the measurements are different.
| Property | Lumbrokinase | Nattokinase |
|---|---|---|
| Catalog activity | ≥20,000 U/g | ≥20,000 FU/g |
| Unit basis | Lysis zone on a fibrin plate against a standard | A defined absorbance change during fibrin degradation |
| Result basis | Per gram of preparation as sold | Per gram of preparation as sold |
| Conversion to the other | None without the methods | None without the methods |
“U” is not a universal enzyme unit. A lumbrokinase U and a nattokinase FU are both defined by their assay sheets, and a third supplier may use a different standard under the same letter. Two certificates that both say 20,000 are comparable only when the plate, the substrate, the standard, the time, the temperature and the reading rule are the same. The methods page explains why a method is only useful when it names its limits.
Fibrin plate against the spectrophotometer
The lumbrokinase assay is usually run on a fibrin plate. Fibrinogen is converted to fibrin in an agarose layer, a dilution of the powder is placed in a well, the plate is incubated, and the cleared zone is measured and compared with a standard. The plate, the fibrin source, the standard, the incubation time and the reading rule define the unit. A plate assay is a comparison of zones, so it is sensitive to the reference and to the reading method.
The nattokinase assay is commonly a spectrophotometric measurement of fibrin degradation, with the unit defined by a fixed absorbance change per minute at 275 nm. The result is still a rate, and it still depends on the substrate, the pH, the temperature and the detection step. The nattokinase specification can be read on the nattokinase product page.
| Element | Lumbrokinase | Nattokinase |
|---|---|---|
| Format | Fibrin plate, zone measurement | Spectrophotometric fibrin degradation |
| Detection | Cleared zone against a standard | Absorbance change per minute |
| Definition | Standard and reading rule named on the sheet | Fixed absorbance change named on the sheet |
| Main variables | Plate, fibrin source, standard, incubation | Substrate, pH, temperature, detection |
Neither assay identifies the protein that produced the activity. A different protease can clear a fibrin plate or move an absorbance reading. That is why the protein pattern and the source record sit beside the activity in both files, and why the lumbrokinase identity page places the activity as one layer rather than the whole proof.
Earthworm tissue against a fermentation
Lumbrokinase is extracted from earthworm tissue, so its source record names a species, a tissue and an origin, and its batch variation starts with the raw material. Nattokinase is produced by fermentation with Bacillus subtilis natto, so its source record names a strain and a fermentation process, and soy is part of its allergen story. The difference is not a quality hierarchy; it is a difference in what the buyer has to audit.
The animal origin changes the documentation. A lumbrokinase file should carry a species and tissue statement and an animal-origin questionnaire; a mammalian TSE questionnaire does not map neatly onto an invertebrate source, but the buyer's reviewer may still ask for it. The nattokinase file should carry the strain, the soy source and the allergen declaration. Each product's regulatory route is separate, and the destination review has to be done on the actual material rather than on the category “enzyme”.
The catalog figures side by side
| Parameter | Lumbrokinase | Nattokinase |
|---|---|---|
| CAS number | 556743-18-1 | 9014-01-1 |
| Source | Earthworm tissue | Bacillus subtilis natto fermentation |
| Activity | ≥20,000 U/g, fibrin plate | ≥20,000 FU/g, spectrophotometric |
| Appearance | White to off-white powder | Off-white to light tan powder |
| Loss on drying | ≤5.0% | ≤8.0% |
| pH (1% solution) | Not a catalog limit | 6.0–8.0 |
| Microbiology | APC ≤1,000 cfu/g | APC ≤10,000 cfu/g |
| Particle size | ≥95% through 40 mesh | ≥95% through 40 mesh |
The table compares specifications; it does not rank them. The two products carry different moisture and microbiology limits because they are different preparations, and a buyer who applies one product's limits to the other will reject conforming lots or accept non-conforming ones.
The label and the unit
The label should name the ingredient and the activity on a stated basis. “Lumbrokinase 20,000 U/g” and “nattokinase 20,000 FU/g” are not interchangeable declarations, and a blend that contains both needs each activity declared on its own basis. A combined “fibrinolytic enzyme blend” figure does not tell the buyer how much of either preparation is present.
“Fibrinolytic” describes an in-vitro assay, not a benefit. Neither ingredient should be presented with a disease-related claim, and the label review belongs to the destination market. The wording rules are set out on the lumbrokinase compliance page; the nattokinase file has its own review. A certificate is not a claim approval, and no claim review moves the unit.
When to choose which
Choose lumbrokinase when the formula is built on an earthworm-derived preparation and the specification is written around a fibrin-plate unit. Choose nattokinase when the formula is built on a fermentation-derived enzyme and the specification is written around FU. The choice is a source and label decision first, and an activity comparison second, because the two numbers are not on the same scale.
If the formula contains both, assay each one separately and declare each activity. A single fibrin-based assay can respond to both preparations, so a combined result cannot show that either one is present at its declared level. For a third option in the same category, the serratiopeptidase specification uses a casein unit, which is a third scale again.
The catalog figures for this product are on the lumbrokinase product page; the grades page covers activity and particle form; the COA page shows how the unit is reported; the quality page describes the release workflow.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation